Literature DB >> 31842686

MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity - Yes.

Maria Isabel Leite1, Douglas Kazutoshi Sato2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31842686     DOI： 10.1177/1352458519868796

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  4 in total

1.  Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.

Authors:  Chuxin Huang; Weidao Chen; Baiyun Liu; Ruize Yu; Xiqian Chen; Fei Tang; Jun Liu; Wei Lu
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

2.  Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Tetsuya Akaishi; Tatsuro Misu; Kazuo Fujihara; Toshiyuki Takahashi; Yoshiki Takai; Shuhei Nishiyama; Kimihiko Kaneko; Juichi Fujimori; Tadashi Ishii; Masashi Aoki; Ichiro Nakashima
Journal:  J Neurol       Date:  2021-11-25       Impact factor: 6.682

3.  Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.

Authors:  Jinming Han; Keying Zhu; Kai Zhou; Ramil Hakim; Sreenivasa Raghavan Sankavaram; Klas Blomgren; Harald Lund; Xing-Mei Zhang; Robert A Harris
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

4.  Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients.

Authors:  Friederike Held; Sudhakar Reddy Kalluri; Achim Berthele; Ana-Katharina Klein; Markus Reindl; Bernhard Hemmer
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.